Morgan Stanley Maintains Equal-Weight on Chemours, Raises Price Target to $17
Chemours Co. -0.69% Pre
Chemours Co. CC | 22.89 22.89 | -0.69% 0.00% Pre |
Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:
CC) with a Equal-Weight and raises the price target from $15 to $17.